Evidence map›Paper›PMID 38977779›Full record

ArticleScientific reports2024

Enhancing brain tumor segmentation in MRI images using the IC-net algorithm framework.

Chandra Sekaran D S, J Christopher Clement

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chandra Sekaran D S *School of Electronics Engineering, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India.
J Christopher Clement *School of Electronics Engineering, Vellore Institute of Technology, Vellore, Tamilnadu, 632014, India. christopher.clement@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors, often referred to as intracranial tumors, are abnormal tissue masses that arise from rapidly multiplying cells. During medical imaging, it is essential to separate brain tumors from healthy tissue. The goal of this paper is to improve the accuracy of separating tumorous regions from healthy tissues in medical imaging, specifically for brain tumors in MRI images which is difficult in the field of medical image analysis. In our research work, we propose IC-Net (Inverted-C), a novel semantic segmentation architecture that combines elements from various models to provide effective and precise results. The architecture includes Multi-Attention (MA) blocks, Feature Concatenation Networks (FCN), Attention-blocks which performs crucial tasks in improving brain tumor segmentation. MA-block aggregates multi-attention features to adapt to different tumor sizes and shapes. Attention-block is focusing on key regions, resulting in more effective segmentation in complex images. FCN-block captures diverse features, making the model more robust to various characteristics of brain tumor images. Our proposed architecture is used to accelerate the training process and also to address the challenges posed by the diverse nature of brain tumor images, ultimately leads to potentially improved segmentation performance. IC-Net significantly outperforms the typical U-Net architecture and other contemporary effective segmentation techniques. On the BraTS 2020 dataset, our IC-Net design obtained notable outcomes in Accuracy, Loss, Specificity, Sensitivity as 99.65, 0.0159, 99.44, 99.86 and DSC (core, whole, and enhancing tumors as 0.998717, 0.888930, 0.866183) respectively.

Indexed as

AlgorithmsBrain NeoplasmsMagnetic Resonance ImagingHumansImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedNeural Networks, Computer

Identifiers

PMID38977779
PMCPMC11231217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.